Diana Hall

Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

Effat S. Emamian, Diana Hall, Morris J. Birnbaum et al. · Nature Genetics · 2004 · 920 citations

Medicine, Neurobiology, Neuroscience +14

Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism

Lalitha Iyer, Diana Hall, Sudip Das et al. · Clinical Pharmacology & Therapeutics · 1999 · 353 citations

Veterinary Medicine, Genetics, Molecular Genetics +15

Sequence Variants of the Brain-Derived Neurotrophic Factor (BDNF) Gene Are Strongly Associated with Obsessive-Compulsive Disorder

Diana Hall, Alefiya Dhilla, Anna Charalambous et al. · The American Journal of Human Genetics · 2003 · 274 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, <i>PPP3CC</i> , encoding the calcineurin gamma subunit

David J. Gerber, Diana Hall, Tsuyoshi Miyakawa et al. · Proceedings of the National Academy of Sciences · 2003 · 257 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates

Diana Hall, Gustavo Ybazeta, Giovanni Destro‐Bisol et al. · Pharmacogenetics · 1999 · 149 citations

Life Sciences, Genetics, Molecular Genetics +16